Evidence map›Paper›PMID 42393042›Full record

ArticleNature communications2026

CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease.

Sanja Brolih, Hafiz Saqib Ali, Caroline Scott, Aude-Anais Olijnik, Hazel Aitkenhead, Gemma Moir-Meyer, Angeline E Gavard, Yuliana Yosaatmadja, Douglas R Higgs, Veronica Buckle and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sanja Brolih *Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Hafiz Saqib Ali *Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, UK.ORCID 0000-0001-5770-5376
Caroline ScottMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0002-1708-7427
Aude-Anais OlijnikMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0002-0980-6663
Hazel AitkenheadCentre for Medicines Discovery, University of Oxford, Oxford, UK.
Gemma Moir-MeyerMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Angeline E GavardCentre for Medicines Discovery, University of Oxford, Oxford, UK.
Yuliana YosaatmadjaCentre for Medicines Discovery, University of Oxford, Oxford, UK.
Douglas R HiggsMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0003-3579-8705
Veronica BuckleMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0003-1195-2608
Noemi RoyDepartment of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Old Road, Headington, Oxford, UK.
Opher GileadiCentre for Medicines Discovery, University of Oxford, Oxford, UK.ORCID 0000-0001-6886-898X
Joseph A NewmanCentre for Medicines Discovery, University of Oxford, Oxford, UK. joseph.newman@cmd.ox.ac.uk.ORCID 0000-0003-4488-0516
Fernanda DuarteChemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, UK. fernanda.duartegonzalez@chem.ox.ac.uk.ORCID 0000-0002-6062-8209
Christian BabbsMRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. christian.babbs@imm.ox.ac.uk.ORCID 0000-0002-1898-5878
Peter J McHughDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. peter.mchugh@imm.ox.ac.uk.ORCID 0000-0002-8679-4627

Funding

Cancer Research UK (CRUK) CRUK/A24759 and DRCRPG-Nov23/100005RCUK | Medical Research Council (MRC) MC_uu_12009, MC_UU_00016
6 · The paper itself

Abstract

Congenital Dyserythropoietic Anaemia type I (CDA-I) is a rare inherited disorder of erythropoiesis, in which erythroid cells display a unique nuclear phenotype referred to as 'spongy' heterochromatin. The molecular basis of CDA-I remains unknown, with most cases of CDA-I caused by mutations in CDAN1, encoding Codanin-1, or CDIN1, encoding for Codanin-1-interacting nuclease 1 (CDIN1). To date, very little is known about the function of CDA-I disease proteins and the mechanism by which their associated mutations cause disease. Here, we demonstrate that endogenous CDIN1 interacts with Codanin-1, to form a stable complex. Structural and functional analysis of this complex reveals that the CDIN1-Codanin-1 complex is an RNA nuclease. We shed light on the key mechanistic features of the complex using biochemical and biophysical approaches, complemented by all-atom molecular dynamics (MD) structural simulations. We identify various functional consequences of founder patient mutations on the RNA nuclease activity of CDIN1, providing a framework for understanding the pathophysiology and developing therapeutic strategies for CDA-I.

Indexed as

Anemia, Dyserythropoietic, CongenitalGlycoproteinsNuclear ProteinsHumansMolecular Dynamics SimulationMutationProtein BindingCDAN1 protein, humanGlycoproteinsNuclear Proteins

Identifiers

PMID42393042
PMCPMC13463051

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.